MetLife Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$992K Sell
173,078
-979
-0.6% -$5.61K 0.01% 1319
2025
Q1
$1.42M Sell
174,057
-5,498
-3% -$44.9K 0.01% 1203
2024
Q4
$1.69M Buy
179,555
+10,056
+6% +$94.7K 0.01% 1132
2024
Q3
$1.81M Hold
169,499
0.01% 1069
2024
Q2
$1.68M Buy
169,499
+24,389
+17% +$242K 0.01% 1062
2024
Q1
$1.71M Sell
145,110
-3,556
-2% -$41.9K 0.01% 1032
2023
Q4
$2.11M Hold
148,666
0.02% 926
2023
Q3
$1.81M Hold
148,666
0.01% 946
2023
Q2
$1.87M Buy
148,666
+2,243
+2% +$28.2K 0.01% 961
2023
Q1
$1.62M Hold
146,423
0.01% 988
2022
Q4
$1.79M Buy
146,423
+947
+0.7% +$11.6K 0.01% 949
2022
Q3
$1.52M Hold
145,476
0.01% 995
2022
Q2
$1.56M Hold
145,476
0.01% 998
2022
Q1
$1.38M Buy
145,476
+50,600
+53% +$479K 0.01% 1154
2021
Q4
$1.1M Hold
94,876
0.01% 1090
2021
Q3
$906K Hold
94,876
0.01% 1166
2021
Q2
$915K Buy
94,876
+11,424
+14% +$110K 0.01% 1221
2021
Q1
$825K Sell
83,452
-21,246
-20% -$210K 0.01% 1252
2020
Q4
$2.42M Sell
104,698
-7,983
-7% -$184K 0.02% 732
2020
Q3
$1.59M Hold
112,681
0.02% 820
2020
Q2
$1.7M Hold
112,681
0.02% 793
2020
Q1
$1.04M Hold
112,681
0.01% 886
2019
Q4
$1.1M Hold
112,681
0.01% 1055
2019
Q3
$904K Buy
112,681
+8,646
+8% +$69.3K 0.01% 1120
2019
Q2
$1.3M Buy
104,035
+18,311
+21% +$229K 0.01% 993
2019
Q1
$1.17M Hold
85,724
0.01% 1018
2018
Q4
$821K Hold
85,724
0.01% 1098
2018
Q3
$1.04M Hold
85,724
0.01% 1104
2018
Q2
$1.34M Hold
85,724
0.02% 918
2018
Q1
$1.29M Buy
85,724
+8,736
+11% +$131K 0.02% 914
2017
Q4
$1.11M Buy
+76,988
New +$1.11M 0.01% 991